Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries.

BACKGROUND Coronary spasm is an established cause for myocardial infarction with unobstructed coronary arteries, and can be diagnosed using intracoronary acetylcholine testing. However, it has been questioned whether such testing is feasible and safe in the acute phase. The aim of this study was to assess the frequency of coronary spasm and the safety of the acetylcholine test in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronaries. METHODS One hundred and eighty selected patients (52% women, mean age 62±13 years) with either myocardial infarction with unobstructed coronary arteries (n=80) or stable angina and unobstructed coronaries (n=100) were enrolled from 2007-2018. All patients underwent the acetylcholine test according to a standardised protocol immediately after diagnostic angiography. Apart from assessment of clinical, demographic and risk factor data, side effects and complications during the acetylcholine test were recorded. RESULTS Overall, epicardial spasm was found in 26% with a higher prevalence among the myocardial infarction with unobstructed coronary arteries compared to the stable angina patients (35% vs 19%, p=0.017). Microvascular spasm was found in 42% with a higher prevalence among the stable patients compared to the myocardial infarction with unobstructed coronary arteries cohort (53% vs 29%, p=0.0014). There were no statistically significant differences in the rate of side effects (16% vs 14%, p=0.674) or complications (1% vs 2.5%, p=0.438) between the two groups. None of the patients experienced irreversible complications. CONCLUSION Coronary spasm is a frequent cause for myocardial infarction with unobstructed coronary arteries. Spasm provocation testing using acetylcholine is feasible in such patients in the acute phase. The complication rate during acetylcholine testing in myocardial infarction with unobstructed coronary arteries patients is low and comparable to patients with stable angina.

[1]  J. Kaski,et al.  MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort , 2019, Journal of Thrombosis and Thrombolysis.

[2]  A. M. Leone,et al.  Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries , 2019, Clinical Research in Cardiology.

[3]  U. Sechtem,et al.  Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA) , 2019, Clinical Research in Cardiology.

[4]  J. Messenger,et al.  Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population. , 2019, European heart journal.

[5]  H. Jneid,et al.  Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association , 2019, Circulation.

[6]  P. Armstrong,et al.  Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. , 2018, International journal of cardiology.

[7]  G. Niccoli,et al.  Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests , 2017, European heart journal.

[8]  E. Prescott,et al.  Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.

[9]  J. Kaski,et al.  Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. , 2017, International journal of cardiology.

[10]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[11]  U. Sechtem,et al.  Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders. , 2016, Journal of visualized experiments : JoVE.

[12]  H. Horiguchi,et al.  Serious Cardiac Complications in Coronary Spasm Provocation Tests Using Acetylcholine or Ergonovine: Analysis of 21 512 Patients From the Diagnosis Procedure Combination Database in Japan , 2015, Clinical cardiology.

[13]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[14]  U. Sechtem,et al.  Transient myocardial ischemia during acetylcholine-induced coronary microvascular dysfunction documented by myocardial contrast echocardiography. , 2013, Circulation Cardiovascular Imaging.

[15]  L. Shaw,et al.  Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. , 2012, JACC. Cardiovascular interventions.

[16]  J. Kaski,et al.  High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.

[17]  U. Sechtem,et al.  Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[18]  K. Klingel,et al.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.

[19]  A. Takeshita,et al.  Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. , 2002, Journal of the American College of Cardiology.

[20]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.